Provided by Tiger Trade Technology Pte. Ltd.

10x Genomics, Inc.

64.72
+0.92001.44%
Post-market: 64.810.0900+0.14%19:59 EDT
Volume:4.13M
Turnover:268.95M
Market Cap:8.43B
PE:-110.00
High:66.94
Open:64.20
Low:62.51
Close:63.80
52wk High:66.94
52wk Low:11.16
Shares:130.29M
Float Shares:118.00M
Volume Ratio:1.28
T/O Rate:3.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5884
EPS(LYR):-0.3490
ROE:-9.40%
ROA:-5.05%
PB:10.21
PE(LYR):-185.42

Loading ...

10x Genomics price target raised to $40 from $23 at Leerink

TIPRANKS
·
Jul 17

U.S. Research Roundup-ibm, MSCI, US Bancorp

Reuters
·
Jul 17

Movement Alert|10x Genomics Falls 5.01% in Regular Trading, Trading at $43.58

Market Focus
·
Jul 16

10x Genomics Schedules Q2 Earnings Release and Conference Call

Reuters
·
Jul 16

10x Genomics Inc : TD Cowen Raises Target Price to $47 from $25

THOMSON REUTERS
·
Jul 15

Movement Alert|10x Genomics Rises 5.27% in Regular Trading, BofA Securities Raises Price Target to $46

Market Focus
·
Jul 14

10x Genomics is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Jul 14

10x Genomics price target raised to $50 from $32 at Canaccord

TIPRANKS
·
Jul 14

BofA Securities Adjusts 10x Genomics Price Target to $46 From $30

MT Newswires Live
·
Jul 13

10x Genomics is Maintained at Equal-weight by Morgan Stanley

Dow Jones
·
Jul 10

Movement Alert|10x Genomics Rises 5.7% in Regular Trading, Trading at $40.95

Market Focus
·
Jul 09

10x Genomics price target raised to $37 from $22 at Morgan Stanley

TIPRANKS
·
Jul 09

U.S. Research Roundup-applied Materials, CME Group, NASDAQ

Reuters
·
Jul 09

10x Genomics is Maintained at Neutral by Citigroup

Dow Jones
·
Jul 09

What Does 10x Genomics' (TXG) Russell Value Index Exit Reveal About Its Evolving Investor Base?

Simply Wall St.
·
Jul 05

10x Genomics is Maintained at Neutral by Piper Sandler

Dow Jones
·
Jul 01

Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (ZBH), Compass Therapeutics (CMPX) and 10x Genomics (TXG)

TIPRANKS
·
Jul 01

Roche Takes Aim at Illumina's Dominance with New Gene Sequencing Machine

Reuters
·
Jun 29

10x Genomics CEO Serge Saxonov Sells 30,000 Shares for $1.04 Million

Reuters
·
Jun 25

10x Genomics is Maintained at Overweight by Barclays

Dow Jones
·
Jun 24